Blood Cancer Research

Help back the next breakthrough

  • attach_money
  • person
  • credit_card

Support brilliant
cancer research today

I'd like to donate

$75
Can help fund one hour of life-saving cancer research.
$125
Can help pay for microscopy to look for immune cells in tumours
$550
Can help fund omics analysis software to study molecular profiles.
$1,000
Can help provide cutting-edge software to analyse cells and help find a cure.
$

All payments are secure & encrypted

Your Details

All payments are secure & encrypted

Donations support Cure Cancer's research grants program across all cancer types.
Blood Cancer Patient Smiling

Blood Cancer at a Glance

Blood cancer affects the way the body produces and regulates blood cells, and includes three main types:
leukaemia, lymphoma and myeloma.

It's estimated that around 20,000 Australians were diagnosed with a
blood cancer in 2025*, making it one of the most commonly diagnosed cancer types in the country.
*Source: Australian Institute of Health and Welfare

Continued research is critical to improving outcomes - Cure Cancer supports the work of emerging researchers investigating new ways to detect, understand and treat all cancer types, including blood cancer.

Our Blood Cancer Research

Cure Cancer has funded more than 170 blood cancer research projects so far, but more research is desperately needed. Supporting the brightest emerging researchers with innovative ideas gives us the best possible chance of finding a cure.
Dr Kate Vandyke, Cure Cancer funded researcher

"Without an established track record in obtaining research grants, it can be near impossible to get one’s foot in the door in many funding schemes. Cure Cancer grants are so highly competitive, as reflected in the high calibre of their recipients. I’m honoured to have been selected – I view it as one of my greatest career achievements to date!"

- Dr Kate Vandyke, a Cure Cancer grant recipient

Meet some of our Blood Cancer Researchers

Dr Emily Gruber

Dr Gruber aims to improve patient outcomes by identifying new biological processes that can be targeted during treatment to eliminate AML cells with minimal impact on normal, healthy tissues. 

Dr Danielle Bond

Dr Bond's research is focused on improving treatments for acute myeloid leukaemia (AML), one of the most aggressive forms of blood cancer, working toward therapies that are more effective and better tolerated by patients.

Dr Heather Murray

Dr Murray is investigating a novel approach to overcoming acute myeloid leukaemia, with the goal of addressing treatment resistance - one of the biggest barriers to long-term survival for AML patients.

Dr Kate Vandyke

Dr Vandyke is exploring new therapeutic targets aimed at preventing drug resistance in blood cancer
treatment, research that could extend the effectiveness of existing therapies for patients who currently run out of options.

Breakthroughs in Blood Cancer Research

From early funding to global recognition

Dr Emily Gruber's research into acute myeloid leukaemia (AML) has been published in Cell - one of the world's leading scientific journals. Her team discovered a new vulnerability in AML cells that could pave the way for future targeted therapies, particularly for patients whose cancer no longer responds to current treatments. It's a powerful example of how investing in promising researchers early can lead to discoveries with global impact.
Dr Emily Gruber, Cure Cancer funded researcher

Why Research Funding Matters

Many of Australia's leading cancer researchers received funding from Cure Cancer at the earliest stages of their careers. Some have gone on to make discoveries recognised around the world.

Emerging researchers drive the breakthroughs that shape how cancer is understood and treated - but early-career funding is scarce and highly competitive. Every donation helps Cure Cancer back the next generation of researchers in Australia, across all cancer types.

How Your Donation Helps

$75

Can help fund an hour of research

$125

Can help fund microscopy imaging to look for immune cells in tumours

$550

Can help fund lab supplies for up to ten vital experiments

$1,000

Can help provide cutting-edge software to analyse cells

Learn More About Blood Cancer

What is blood cancer?

add remove

Blood cancer occurs when normal blood cell production, which happens in the bone marrow, is interrupted by the uncontrolled growth of an abnormal type of blood cell. When abnormal blood cells build up in the blood, it can affect how the rest of the body functions. 

Blood cancer is on the rise in Australia. Around 20,000 Australians are estimated to be diagnosed with a blood cancer in 2025, with the age-standardised incidence rate increasing from 66 cases per 100,000 people in 2003 to 73 cases per 100,000 in 2025*. Continued research is critical to developing better treatments and improving outcomes. 

(*Source: Australian Insititute of Health and Welfare)

What are the types of blood cancer?

add remove
Blood cancers are categorised according to the type of cells affected. There are three main types:

Leukaemia

Leukaemia starts in the bone marrow where developing blood cells (usually white cells) undergo a malignant change. These cells then crowd the marrow, affecting the body’s ability to produce normal blood cells. There are four kinds of leukaemia: acute lymphoblastic, acute myeloid, chronic lymphocytic, and chronic myeloid.

In 2025, an estimated 2,191 deaths in Australia were due to leukaemia. However, survival rates have improved significantly over time. The five-year relative survival rate increased from 43% in 1987–1991 to 66% in 2017–2021.*

(*Source: Cancer Australia)

Symptoms can include:

  • Signs of anaemia

  • Chronic infection (such as fevers, sweats, sores)

  • Enlarged lymph nodes

  • Joint pain

  • Spontaneous bruising and increased bleeding
  • Painful passing of urine



Lymphoma

Lymphomas affect the lymphatic system, part of the immune system which protects the body against disease and infection. These occur when lymphocytes (a type of white blood cell) undergo a malignant change and multiply in an uncontrolled way. The lymphoma cells then accumulate to form tumours in the lymph nodes, which are located throughout the body. There are two types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma, which can be distinguished by the specific lymphocytes involved.

Symptoms can include:

  • Swelling of lymph nodes

  • Fever

  • Night sweats

  • Sudden weight loss
  • Fatigue
  • Shortness of breath



Myeloma

Myeloma develops in plasma cells (a type of white cell) of the bone marrow. It is often called multiple myeloma because marrow is found in multiple bones such as the spine, skull, ribs, pelvis, and shoulder. The five-year survival rate for myeloma is 51%.

Symptoms can include:

  • Kidney problems

  • Frequent nose bleeding

  • Feeling pain in the bones

  • Fatigue

  • Chronic infections that don’t go away

What are the risks associated with blood cancer?

add remove

Exposure to radiation and certain chemicals or solvents is a known risk associated with leukaemia, lymphoma, and myeloma. Infection of HIV, which can weaken the immune system, Epstein-Barr virus (herpes), and Human T-Cell leukaemia virus, can also increase risk.

People assigned male at birth are at a slightly greater risk of lymphoma. Having a family history of Hodgkin lymphoma increases the risk of this disease. This is also more common in early adulthood (people in their 20s). Non-Hodgkin lymphoma is more common in late adulthood (60 above). 

Let's stay in touch

To receive updates on our work, campaigns and our impact in cancer research, subscribe to our newsletter.